Archive · 3 Aug 2025
India Cuts Prices on 35 Essential Medicines
The Indian government is making some medicines cheaper.
The drug price regulator, NPPA, has lowered the prices of 35 essential medicines to help people afford them.
These include medicines for things like heart problems and infections.
Stores are required to show the new, lower prices.
If they don't, they could face penalties.
This aims to make these important medicines easier for people to get.
The NPPA reduced retail prices of 35 essential drugs to improve affordability.
Price cuts affect anti-inflammatory, cardiovascular, and anti-diabetic medicines.
Key formulations include Aceclofenac, Paracetamol, and Atorvastatin combinations.
Retailers must display updated prices prominently.
Non-compliance can lead to penalties under the DPCO, 2013, and Essential Commodities Act, 1955.
- Who
- The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilisers.
- What
- The NPPA reduced retail prices of 35 essential drugs.
- When
- The order was notified by the Ministry of Chemicals and Fertilisers.
- Where
- India
- Why
- To make medicines more affordable for patients.
- Regulatory Body
- National Pharmaceutical Pricing Authority (NPPA)
- Ministry
- Chemicals and Fertilisers
- Number of Drugs
- 35
- Drug Categories
- Anti-inflammatory, Cardiovascular, Antibiotic, Anti-diabetic, Psychiatric
- Price Regulation Basis
- DPCO, 2013 and Essential Commodities Act, 1955
- Retailer Requirement
- Display Updated Price Lists
